Toleranzia AB announced that Thomas Pålsson has been appointed as new chief financial officer (CFO). Thomas, who brings extensive financial and economic expertise from leading roles in Life Science companies, will assume the position as the company's CFO on October 30, 2023. Thomas succeeds the company's outgoing CFO, Torbjörn Sannerstedt.

Thomas Pålsson has 25 years of experience as CFO and Business Controller in Life Science companies and almost 15 years of experience as CFO in listed companies. Previous clients include Albireo AB, Arexis AB, and Integrum AB, while current other CFO assignments include CirChem AB, Monivent AB and Stayble Therapeutics AB. Thomas' solid background includes a Master of Business Administration (MBA) degree from the Gothenburg School of Economics.